Victor Kouassi – Page 7 – REVIVE

About Victor Kouassi

This author has not yet filled in any details.
So far Victor Kouassi has created 162 blog entries.

<br>Getting the most out of antimicrobial surveillance</br><em> – by Mariana Castanheira</em> — 28 May 2020
Getting the most out of antimicrobial surveillance – by Mariana Castanheira
more

CARB-X – How to Prepare for an FDA Pre-IND Meeting: Planning for Success — 18 May 2020
CARB-X – How to Prepare for an FDA Pre-IND Meeting: Planning for Success
more

How to use the Global AMR R&D Hub’s Dynamic Dashboard — How to use the Global AMR R&D Hub’s Dynamic Dashboard
more

<br>COVID-19 and antimicrobial resistance: Are there any unknowns that will become known?</br><em> – by Stephan Harbarth</em> — 13 May 2020
COVID-19 and antimicrobial resistance: Are there any unknowns that will become known? – by Stephan Harbarth
more

<br>COVID-19 and its impact on antimicrobial stewardship</br><em> – by Andrew Seaton</em> — 30 April 2020
COVID-19 and its impact on antimicrobial stewardship – by Andrew Seaton
more

GARDP: Bringing new treatments for drug-resistant infections to all who need them — 22 April 2020
GARDP: Bringing new treatments for drug-resistant infections to all who need them
more

Test tube to patient: PK/PD of fixed dose beta-lactam/beta-lactamase inhibitor combinations — 20 April 2020
Test tube to patient: PK/PD of fixed dose beta-lactam/beta-lactamase inhibitor combinations
more

<br>The critical need for alternative approaches to address antibiotic treatment failure</br><em> – by Bob Hancock</em> — 16 April 2020
The critical need for alternative approaches to address antibiotic treatment failure – by Bob Hancock
more

COVID-19: Pourquoi il est plus important que jamais de s’attaquer à la crise silencieuse des infections résistantes aux médicaments – ...

more

Probability of target attainment analyses for dose selection in antimicrobial drug development — 10 April 2020
Probability of target attainment analyses for dose selection in antimicrobial drug development
more